* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced
Dish of the day
Admissions:
None
Delistings:
Forward Partners Group (FWD.L) has left AIM following its acquisition by Molten Ventures (GROW.L)
What’s baking in the oven? **
Potential**** Initial Public Offerings:
None
Reverse Takeovers:
None
Change of Market:
None
Banquet Buffet***
Alien Metals 0.12p £7.6m (UFO.L)
The company focuses on the exploration and development of the Hancock iron ore project and the Pinderi Hills project in Western Australia, advises that it has entered a short-term funding facility. A funding package of up to A$2m has been made available through a one-year convertible loan note, at of SOFR (Secured Overnight Financing Rate) (being circa 5.3% as at the date of this announcement) plus 10% per annum. The lender is Bennelong Resource Capital Pty Limited, a 7.2% shareholder. Furthermore, the Company announced the appointment of Technical Director, Mr. Rob Mosig, as a Non-Executive Director.
Atlantic Lithium 18.46p £119.9m (ALL.L)
The African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine announces its unaudited results for the half-year period ended 31 December 2023. Loss before income tax was A$5.8m (compared to the loss of A$3.9m in 2022). Cash position was A$9.6m at 31 December 2023 (A$15.3m at 31 December 2022). Exploration and evaluation expenditure held on the balance sheet for the period ended 31 December 2023 was A$19.7m (30 June 2023: A$18.0m) which is net of Piedmont contributions. The Company remains on track to break ground in Q4 2024 for its Ewoyaa Lithium Project.
Biome Technologies 107.5p £4.1m (BIOM.L)
The bioplastics and radio frequency technology business announces that its RF Technologies division has been awarded a further contract win. The contract has a revenue value of £536k to supply two radio frequency welding systems for use by an international corporation in the medical supply sector. The systems will use a modular machine platform which integrates automation and RF welding. Completion is scheduled within the 2024 financial year, with stage payments being received against milestones during the contract period.
Capital Metals 3.6p £11.2m (CMET.L)
The mineral sands company approaching mine development stage at the high-grade Eastern Minerals Project in Sri Lanka, announces the strategic acquisition of 10% of the Company at 3.623p per share by Sheffield Resources Limited, the 50% owner of the Thunderbird mineral sands mine in Western Australia. There is a 12-month option for Sheffield to invest a further £0.844m at 4.891p per share. Outline terms have been agreed with Sheffield to contribute funding to support the Project into production in exchange for up to a 50% interest in the Project subject to, inter alia, due diligence over a 60-day period.
Cornish Metals 9.75p £54.2m (CUSN.L)
The company announces the departure of Chief Executive Officer, Richard Williams, effective on March 31, 2024, when he will also leave the Company's Board. Mr. Williams will remain available to the Company on a consulting basis going forward. Ken Armstrong, Non-Executive Director will step in as Interim CEO and Patrick Anderson, Chairman of the Board, will become the Executive Chairman during the transition and search for a permanent CEO to lead the Company through the next stage of development of South Crofty as the Company moves towards construction.
European Metals 14p £29m (EMH.L)
The mineral exploration and development company advancing the Cinovec vertically integrated battery metals project in Czech Republic, announces its interim results for the half-year ended 31 December 2023 (H1 FY23). Finance income increased to $325k (H1 FY22: $146k). Other income was $985k (H1 FY22: $565k). Loss before income tax decreased to $1.1m (H1 FY22: $3.8m). Cash decreased to $5.7m (30 June 2023 : $8.9m).
Sareum Holdings * 23.5p £16.5m (SAR.L)
The clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, announces that the European Patent Office has issued a Notice of Allowance for a patent relating to SDC-1801, the Company's lead TYK2/JAK1 kinase inhibitor, currently in clinical development in Australia. The newly approved European patent application, EP3864009, safeguards SDC-1801, its medical applications particularly in the treatment of autoimmune diseases, and certain methods of synthesis. This follows approvals in 2023 by the China National Intellectual Property Administration, and the Japan Patent Office for the same protections.
Trident Royalties 35.5p £104m (TRR.L)
The diversified mining royalty company noted some announcements by Lithium Americas Corporation (LAC) that LAC has received a conditional commitment from the U.S. Department of Energy for a $2.26bn loan under the Advanced Technology Vehicles Manufacturing Loan Program for financing the construction of the processing facilities at Thacker Pass. The Loan is intended to help finance the construction of Thacker Pass, targeted to produce an initial 40,000 tonnes per year of battery grade lithium carbonate. Trident holds a net 1.05% gross revenue royalty over Thacker Pass (after expected exercise of a partial royalty buyback, which would see $13.2m to Trident).
Wishbone Gold 1.25p £3.8m (WSBN.L)
The gold and precious metals exploration company with assets in Australia, announces that initial results from the diamond drill program at its 100% owned Cottesloe Project has highlighted significant mineralisation potential. The information gathered to date is highly encouraging, confirming the overall exploration model for a major sediment hosted metals system focused on base metals and silver. The base metals identified are critical to the development of lithium-ion batteries used in electric vehicles and in energy storage systems integral to the global push towards lower carbon emissions.
Zephyr Energy 2.7p £45.5m (ZPHR.L)
The Rocky Mountain oil and gas company focused on responsible resource development from carbon-neutral operations, announces that following a detailed selection process, Zephyr has signed a rig contract with Helmerich & Payne for its Rig 257 which will be used to redrill the State 36-2 well on the Company's project in the Paradox Basin, Utah, U.S. Rig 257 is a Flex 3 1,500HP drilling rig fully capable of drilling the planned well and managing the high reservoir pressures expected to be encountered. The rig is wrapping up a sustained and successful drilling campaign in the nearby Uinta Basin and will mobilise to the State 36-2R well site in the near-term, with an expected spud in mid-April.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.